References
- Rugolo LMSS, Bentlin MR, Trindade CEP. Preeclampsia: early and late neonatal outcomes. NeoReviews. 2012;13:e532–e541.
- Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017;39:496–512.
- Tranquilli AL. Introduction to ISSHP new classification of preeclampsia. Pregnancy Hypertens. 2013;3:58–59.
- Rugolo LMSS, Bentlin MR, Trindade CEP. Preeclampsia: effect on the fetus and newborn. NeoReviews. 2011;12:e198:e2006.
- Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract. 2013;22(Suppl1):8–19.
- Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia – two placental causes of preeclampsia? Placenta. 2014;35:S20–SS25.
- Ferguson KK, Meeker JD, McElrath TF, et al. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am J Obstet Gynecol. 2017;216:527.e1–527.e9.
- Harmon AC, Cornelius DC, Amaral LM, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016;130:409–419.
- Jakaitis BM, Denning PW. Human breast milk and the gastrointestinal innate immune system. Clin Perinatol. 2014;41:423–435.
- Erbağci AB, Cekmen MB, Balat O, et al. Persistency of high proinflammatory cytokine levels from colostrum to mature milk in preeclampsia. Clin Biochem. 2005;38:712–716.
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1–SS22.
- Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:13–59.
- Agarwal S, Karmaus W, Davis S, et al. Immune markers in breast milk and fetal and maternal body fluids: a systematic review of perinatal concentrations. J Hum Lact. 2011;27:171–186.
- Lau SY, Guild SJ, Barrett CJ, et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013;70:412–427.
- Trend S, Strunk T, Lloyd ML, et al. Levels of innate immune factors in preterm and term mothers’ breast milk during the 1st month postpartum. Br J Nutr. 2016;115:1178–1193.
- Patel AL, Johnson TJ, Engstrom JL, et al. Impact of early human milk on sepsis and health-care costs in very low birth weight infants. J Perinatol. 2013;33:514–519.
- Etem Pişkin İ, Nur Karavar H, Araslı M, et al. Effect of maternal smoking on colostrum and breast milk cytokines. Eur Cytokine Netw. 2012;23:187–190.
- Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1999;117:550–555.
- Jonsson Y, Rubèr M, Matthiesen L, et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol. 2006;70:83–91.
- Szarka A, Rigó J, Lázár L, et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
- Bryan DL, Hawkes JS, Gibson RA. Interleukin-12 in human milk. Pediatr Res. 1999;45:858–859.
- Ballard O, Morrow AL. Human milk composition nutrients and bioactive factors. Pediatr Clin North Am. 2013;60:49–74.
- Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878–888.
- Watson CJ, Kreuzaler PA. Remodeling mechanisms of the mammary gland during involution. Int J Dev Biol. 2011;55:757–762.